Maritop

Topiramate, the active ingredient in Maritop, is an antiepileptic presented as an oral dosage form for oral use. It treats partial seizures and is used for migraine prophylaxis in adults.\nGNH India supplies Maritop as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Topiramate is an antiepileptic that acts on neuronal excitability and is employed in specific neurological conditions.\n\nPartial seizures: reduces the frequency and severity of focal seizure episodes.\nMigraine prophylaxis: decreases the number of migraine attacks and lessens headache intensity.

Topiramate may cause a range of adverse reactions, from mild to serious.\n\nCommon Side Effects:\n- Dizziness\n- Fatigue\n- Tingling or numbness in the limbs\n- Decreased appetite or weight loss\n\nSerious or Rare Side Effects:\n- Metabolic acidosis\n- Kidney stones\n- Acute angle‑closure glaucoma\n- Severe allergic reactions (e.g., rash, swelling)\n- Suicidal thoughts or behavior

Topiramate requires careful consideration of several safety factors before and during therapy.\n\nPregnancy: Category D – avoid unless benefits outweigh risks.\nRenal impairment: dose may need adjustment; monitor kidney function.\nConcomitant carbonic anhydrase inhibitors: increased risk of metabolic acidosis.\nHistory of kidney stones: monitor for recurrence.\nStore at room temperature: keep in original container, protect from moisture and direct sunlight.

Topiramate can interact with other medicines, altering efficacy or safety.\n\nMajor Interactions (Avoid):\n- Co‑administration with strong CYP2C19 inhibitors (e.g., fluconazole) may increase topiramate levels.\n- Combined use with other carbonic anhydrase inhibitors (e.g., acetazolamide) raises risk of acidosis.\n\nModerate Interactions (Monitor Closely):\n- Oral contraceptives: topiramate may reduce hormonal efficacy; consider alternative contraception.\n- Antidiabetic agents: monitor blood glucose as topiramate can affect glycemic control.